1. Home
  2. DOMO vs RCEL Comparison

DOMO vs RCEL Comparison

Compare DOMO & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DOMO
  • RCEL
  • Stock Information
  • Founded
  • DOMO 2010
  • RCEL N/A
  • Country
  • DOMO United States
  • RCEL United States
  • Employees
  • DOMO N/A
  • RCEL N/A
  • Industry
  • DOMO Computer Software: Prepackaged Software
  • RCEL Medical/Dental Instruments
  • Sector
  • DOMO Technology
  • RCEL Health Care
  • Exchange
  • DOMO Nasdaq
  • RCEL Nasdaq
  • Market Cap
  • DOMO 562.5M
  • RCEL 113.7M
  • IPO Year
  • DOMO 2018
  • RCEL N/A
  • Fundamental
  • Price
  • DOMO $17.31
  • RCEL $6.76
  • Analyst Decision
  • DOMO Buy
  • RCEL Strong Buy
  • Analyst Count
  • DOMO 8
  • RCEL 4
  • Target Price
  • DOMO $15.13
  • RCEL $13.75
  • AVG Volume (30 Days)
  • DOMO 905.2K
  • RCEL 1.2M
  • Earning Date
  • DOMO 08-27-2025
  • RCEL 11-06-2025
  • Dividend Yield
  • DOMO N/A
  • RCEL N/A
  • EPS Growth
  • DOMO N/A
  • RCEL N/A
  • EPS
  • DOMO N/A
  • RCEL N/A
  • Revenue
  • DOMO $318,363,000.00
  • RCEL $74,884,000.00
  • Revenue This Year
  • DOMO $1.78
  • RCEL $22.92
  • Revenue Next Year
  • DOMO $2.66
  • RCEL $37.07
  • P/E Ratio
  • DOMO N/A
  • RCEL N/A
  • Revenue Growth
  • DOMO N/A
  • RCEL 38.32
  • 52 Week Low
  • DOMO $6.01
  • RCEL $3.60
  • 52 Week High
  • DOMO $17.88
  • RCEL $14.16
  • Technical
  • Relative Strength Index (RSI)
  • DOMO 63.95
  • RCEL 75.67
  • Support Level
  • DOMO $13.85
  • RCEL $4.12
  • Resistance Level
  • DOMO $17.88
  • RCEL $4.44
  • Average True Range (ATR)
  • DOMO 0.92
  • RCEL 0.34
  • MACD
  • DOMO 0.28
  • RCEL 0.19
  • Stochastic Oscillator
  • DOMO 85.86
  • RCEL 88.00

About DOMO Domo Inc. Class B

Domo Inc provides a cloud-based platform that digitally connects all the data, systems, and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: